Breast cell line dose response to target inhibition measured by high throughput microscopy - Dataset (ID:20136)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | Drug Concentration | Conc Units | Timepoint | Timepoint Units | Measured pERK (Alexa 488) | Measured p-Rb (Alexa 568) | Alexa Fluor 647 | Measured p-Akt/p-4EBP1/p-S6 (Alexa 647) | Image |
---|---|---|---|---|---|---|---|---|---|---|
GSK1059615 | MCF 10A | 3.16 | nM | 24 | hr | 367.96 | 143.08 | p-Akt | 41.13 | |
MK2206 | MCF 10A | 3.16 | nM | 6 | hr | 401.94 | 154.74 | p-Akt | 43.87 | |
MK2206 | MCF 10A | 3.16 | nM | 24 | hr | 313.82 | 137.95 | p-Akt | 41.12 | |
Triciribine | MCF 10A | 3.16 | nM | 6 | hr | 404.45 | 155.90 | p-Akt | 44.15 | |
Triciribine | MCF 10A | 3.16 | nM | 24 | hr | 272.12 | 127.39 | p-Akt | 34.72 | |
Dactolisib | MCF 10A | 3.16 | nM | 6 | hr | 394.32 | 173.00 | p-Akt | 43.59 | |
Dactolisib | MCF 10A | 3.16 | nM | 24 | hr | 306.83 | 142.69 | p-Akt | 34.75 | |
Gefitinib | T47D | 3.16 | nM | 6 | hr | 181.54 | 100.89 | p-Akt | 103.21 | |
Gefitinib | T47D | 3.16 | nM | 24 | hr | 164.50 | 108.71 | p-Akt | 78.14 | |
Torkinib | T47D | 0.422 | nM | 6 | hr | 170.81 | 90.25 | p-Akt | 78.90 | |
Torkinib | T47D | 0.422 | nM | 24 | hr | 165.87 | 94.49 | p-Akt | 59.39 | |
GSK1059615 | T47D | 3.16 | nM | 6 | hr | 165.75 | 87.48 | p-Akt | 92.56 | |
GSK1059615 | T47D | 3.16 | nM | 24 | hr | 161.44 | 94.40 | p-Akt | 65.08 | |
MK2206 | T47D | 3.16 | nM | 6 | hr | 101.19 | 50.29 | p-Akt | 14.05 | |
MK2206 | T47D | 3.16 | nM | 24 | hr | 161.28 | 93.73 | p-Akt | 49.64 | |
Triciribine | T47D | 3.16 | nM | 6 | hr | 96.97 | 52.42 | p-Akt | 20.09 | |
Triciribine | T47D | 3.16 | nM | 24 | hr | 157.47 | 91.95 | p-Akt | 63.67 | |
Dactolisib | T47D | 3.16 | nM | 6 | hr | 112.31 | 65.77 | p-Akt | 19.14 | |
Dactolisib | T47D | 3.16 | nM | 24 | hr | 138.41 | 87.20 | p-Akt | 40.75 | |
Gefitinib | AU565 | 10.0 | nM | 6 | hr | 241.48 | 51.68 | p-Akt | 25.73 | |
Gefitinib | AU565 | 10.0 | nM | 24 | hr | 525.48 | 125.00 | p-Akt | 138.40 | |
Torkinib | AU565 | 1.78 | nM | 6 | hr | 231.62 | 48.81 | p-Akt | 18.34 | |
Torkinib | AU565 | 1.78 | nM | 24 | hr | 442.08 | 102.06 | p-Akt | 74.88 | |
GSK1059615 | AU565 | 10.0 | nM | 6 | hr | 218.56 | 55.54 | p-Akt | 24.76 | |
GSK1059615 | AU565 | 10.0 | nM | 24 | hr | 440.93 | 111.08 | p-Akt | 88.89 | |